Most importers feel confident in their Foreign Supplier Verification Program until one moment: the FDA issues a Notice of Inspection. What catches companies off guard isn’t the inspection itself—it’s the speed, precision, and record-centered depth with which investigators evaluate whether your FSVP exists, is implemented correctly, and actually reflects the risks in your supply chain.

FSVP audits are among the most unforgiving reviews FDA conducts. They are designed to expose gaps quickly and to hold the U.S. importer accountable, even when the foreign supplier’s systems appear strong. This guide breaks down what really happens during an FSVP audit and why importers who think they are prepared often aren’t.

Why the FDA’s FSVP Audit Model Feels Different

Most regulatory audits allow for conversation, clarification, or corrective demonstrations. FSVP is different. Almost every conclusion the FDA reaches is based on whether your records match:

• The hazards associated with your products
• The controls implemented by your foreign supplier
• The risk-based verification activities you selected

If these three elements do not align, investigators consider the program inadequate. It’s common for importers to realize during the audit that their written procedures don’t match what personnel are actually doing—one of the most frequent causes of enforcement.

For importers wanting to revisit their foundational documents before an audit, start with FSVP verification essentials.

The Audit Trigger: How FDA Decides to Inspect You

FSVP audits may occur:

• As routine FSMA surveillance
• Following import entry reviews
• After significant supplier incidents
• In response to consumer complaints or outbreak investigations

Most companies receive no advance notice beyond Form 482, the standard notification of inspection. From that moment, the clock starts.

What Happens in the First Minutes of an FSVP Audit

Once the investigator arrives, they will immediately request:

• Your written FSVP
• Hazard analyses
• Supplier evaluations and approval rationale
• Verification activity records
• Evidence of reanalysis

Unlike facility inspections, FDA does not tour your operations or observe production. The audit is almost entirely a document-for-document evaluation. If your records are incomplete, inconsistent, or not readily retrievable, the investigator writes the deficiency into the file.

The Core Review: What FDA Examines Most Closely

Investigators focus on five areas because they reveal the strength—or failure—of an FSVP:

1. Hazard Analysis Quality

Is the hazard analysis product-specific, risk-based, and reviewed by a qualified individual? Does it identify who controls each hazard? If your analysis is generic or outdated, the FDA notes it immediately.

2. Supplier Approval Decisions

Does your supplier’s performance justify approval? Many importers list a supplier as “approved” with no written rationale, no historical review, and no evaluation of corrective actions.

3. Verification Activities

Were the activities selected actually appropriate for the hazards? For example, testing alone rarely satisfies verification for high-risk suppliers. FDA expects logic, not convenience.

4. Alignment Between Records and Reality

Do your written procedures match your actual practices? If the investigator interviews staff and hears a different process than what appears in your FSVP, this misalignment is cited.

5. Qualified Individual Involvement

Was a properly trained individual involved in the evaluation and approval process? Lack of PCQI or FSVP training is one of the most consistent findings across Warning Letters.

Importers who want clarity on common qualified-individual pitfalls often refer to audit risks PCQIs can prevent.

Where Importers Most Frequently Get Caught

Certain mistakes appear so consistently that investigators expect to find them. These include:

Missing or Boilerplate Hazard Analyses

Generic hazard analyses signal to FDA that the importer has not evaluated the supplier’s actual process. This often leads investigators to review multiple product lines.

Supplier Approval Without Documentation

“Approved” means nothing if the rationale isn’t recorded. FDA will consider the supplier effectively “not evaluated” if documents aren’t present.

Incomplete or Inappropriate Verification Activities

When importers choose minimal verification activities—or choose them for convenience—investigators note the gap immediately.

Failure to Reassess Suppliers

Reassessment is required at least every three years. Many companies fail to document this step, even if their supplier has not changed.

Broken Internal Communication

When procurement, QA, and leadership are not aligned, the FSVP falls apart under audit pressure. FDA expects that all responsible parties can explain the program.

Lack of Alignment With HACCP or Preventive Controls

If supplier controls do not logically align with the hazards in your analysis, FDA views the entire program as structurally weak. A deeper look at control failures is available in top HACCP audit failures.

What Happens When FDA Finds a Deficiency

FDA’s findings range from informal investigator notes to formal citations:

• Verbal or written feedback during the audit
• Form FDA-483a, FSVP observations
• Warning Letters published publicly
• Potential import holds

If a deficiency appears, FDA expects prompt corrective action.

Why FSVP Audits Create Urgency for Training

FSVP is a regulation built on interpretation—and interpretation requires training. The most consistently cited deficiencies are tied to misunderstandings of what FDA considers a risk-based verification.

Companies with formally trained FSVP personnel are significantly more likely to:

• Produce records that meet FDA expectations
• Demonstrate appropriate hazard evaluations
• Justify supplier approval decisions
• Prepare corrective actions when needed

Many importers choose Registrar Corp because they want a training program that matches the depth of an actual FDA inspection. For an overview of why, see why importers trust Registrar.

Your Next Step: Strengthen Your Team Before FDA Arrives

An FSVP audit reveals the truth about your program—not just its existence, but its accuracy, logic, and implementation. If your team is unsure how to evaluate hazards, justify supplier approval, or select verification activities with FDA-level reasoning, formal FSVP training provides immediate alignment.

Registrar Corp’s FSVP Training offers:

• Step-by-step guidance through every regulatory requirement
• Practical examples of real audit findings
• Tools that help importers prevent the most common causes of failure
• Insight from professionals who work with FDA expectations daily

If you want an FSVP that withstands audit pressure—not just in theory, but in practice—explore Registrar Corp’s FSVP Training today.